In recent years, you may have seen headlines like: Weight-loss or diabetes drug may reduce dementia risk. The drugs in question are GLP-1 receptor agonists (GLP-1 RAs) such as Semaglutide (Ozempic/Wegovy), Liraglutide (Victoza/Saxenda), and others
And for many patients, it dramatically reduces obesity-related conditions like type 2 diabetes, high blood pressure and heart disease. Looking Ahead: The Future of Weight Management The emergence of non-injectable GLP-1 medications signals a future where weight management is more personalized, flexible and patient-centered than ever before
Vitamins B1+B6+B12 ( NEURO BION) contains clinically proven nerve-nourishing B vitamins that protects and nourishes your nerve with proper diet and exercise
Semaglutide GLP-1 is an FDA-approved weight loss injection for long-term weight control in obese and overweight adults
Given that GLP-1 RAs significantly reduce weight and improve metabolic health, millions of patients have become candidates for these drugs
